MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurobehavioral disorders"

  • MDS Virtual Congress 2020

    Impulsive Control Behaviours in Patients with GBA, PARK2 and without Mutations in Genes Associated to Parkinson’s Disease

    P. Amami, T. De Santis, B. Garavaglia, A. Albanese (Rozzano, Italy)

    Objective: Aim of the study was to assess prevalence and severity of ICBs in PD patients with GBA mutations. Background: Parkinson disease (PD) is a…
  • MDS Virtual Congress 2020

    GWAS on impulse control disorders in Parkinson’s disease

    S. Bekadar, F.X Lejeune, F. Danjou, M. Vidailhet, M. Anheim, A. Elbaz, G. Alves, O.B Tysnes, A.H Erga, J. Maple-Grodem, A. Brice, J.C Corvol (Paris, France)

    Objective: To identify the genetic factors associated with Impulse control disorders (ICDs) in Parkinson’s disease (PD) patients using a genome-wide approach. Background: ICDs are associated…
  • MDS Virtual Congress 2020

    Quantitative Evaluation of Iron Content in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

    J. Sun, Z. Lai, J. Ma, L. Gao, M. Chen, J. Chen, J. Fang, Y. Fan, Y. Bao, D. Zhang, P. Chan, Q. Yang, C. Y, T. Wu, T. Ma (Beijing, China)

    Objective: The aim of this study was to quantitatively evaluate iron content in idiopathic rapid eye movement sleep behavior disorder patients using quantitative susceptibility mapping.…
  • MDS Virtual Congress 2020

    Association between impulse control disorders and depression in drug-naïve Parkinson’s disease

    A. Karukote, S. Thakolwiboon, P. Julayanont (Lubbock, TX, USA)

    Objective: To determine the association between depression and impulse control disorders (ICDs) in patients with Parkinson's disease (PD). Background: Depression is one of the most…
  • MDS Virtual Congress 2020

    Therapeutic Benefits of Music for Three Types of Neurological Disorders: an fNIRS Study Protocol for Controlled Trial in Dalian, China, Part 1-Parkinson’s Disease

    LL. Pu, Z.H Liang, W.C Tang, F.Y Cong, B.W Zhang, N.K Qureshi, J. Ly, T. Li (Dalian, China)

    Objective: It is investigated that the external auditory stimuli affect motor synchronization and control in patients with PD,and further studied that how music therapy or other…
  • MDS Virtual Congress 2020

    Changes in the AKT/GSK3 pathway in the cerebellum increase susceptibility to movement disorders in a rat model of post-traumatic stress disorder

    G. Ngoupaye, M. Mabandla (Durban, South Africa)

    Objective: In an effort to investigate the role of PTSD in the aetiology of movement disorders, we assessed changes related to PTSD using the neurotrophic…
  • 2019 International Congress

    Grey-matter volume changes underpinning irritability and aggression in early manifest Huntington’s disease

    S. Martinez-Horta, F. Sampedro, J. Perez-Perez, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore grey-matter volume (GMV) differences between early-stage Huntington's disease (HD) patients with and without significant irritability/aggression symptoms (IAs) and to assess it association…
  • 2019 International Congress

    Clinical and cognitive features of anxiety in Parkinson’s disease

    G. Carey, L. Defebvre, A. Moonen, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To determine the demographic, clinical and cognitive features associated with anxiety disorders in Parkinson’s disease (PD). Background: The point prevalence of anxiety disorders in…
  • 2019 International Congress

    Progression of neuropsychiatric symptoms in Parkinson’s disease

    J. Dlay, G. Duncan, T. Khoo, C. Williams-Gray, D. Breen, R. Barker, D. Burn, R. Lawson, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the progression of neuropsychiatric symptoms (NPS) in Parkinson’s disease (PD) and their associations with quality of life (QoL) and motor problems. Background:…
  • 2019 International Congress

    Defence Mechanism of Ego and Coping Strategy Style of the Patient with Parkinson’s Disease

    M. Kulsum, S. Choudhury, A. Ghosh, P. Ghosh (Kolkata, India)

    Objective: To find out the prevalence of different defence mechanism and coping strategies in the patients with PD.To find out the relationship between using of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley